The Verge: “The Food and Drug Administration authorized a second at-home antiviral pill to treat COVID-19 on Thursday. The clearance for the drug, called molnupiravir, came a day after the agency signed off on Pfizer’s COVID-19 antiviral, called Paxlovid. Both drugs reduce the risk of hospitalization and death in people diagnosed with COVID-19 and at… Continue Reading